GENE ONLINE|News &
Opinion
Blog

2018-10-04| PartnerAsia-Pacific

【Event Information】Med x Tech Summit Asia (MEDTEX) will debut on Nov 29th – 30th in Taipei, Taiwan!

by GeneOnline
Share To

From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, MEDTEX brings over 30 cross-industry global key opinion leaders to Taipei.

MEDTEX welcomes world-renowned experts Including Microsoft, Google AI, Takeda, Mayo Clinic, Merck, Teva, Harvard Medical School, NVIDIA, etc. to discuss Immune-Oncology, Delivering Personalized Healthcare through Precision Medicine, Intelligent Healthcare, Blockchain, Big Data, and other popular topics in this intensive 2-day event.

Taiwan Healthcare+ Expo is the signature expo in Asia Pacific that provides solutions for medicine, health, and care. Starting from all aspects of healthcare needs, the expo strategically connects electronics, IT, biotech, pharmaceuticals, medical devices, precision machinery, precision medicine, health management industries along with the biomedical innovators from Israel, US, Germany, Singapore, Australia together.

With 400+ major medical centers, technology, pharmaceutical, medical devices organizations participating, MEDTEX and Healthcare+ Expo are for medical professionals, IT, device, pharmaceutical, and biotech companies who wants to find new opportunities and partnering with global healthcare industry players in Asia. All expo attendees also have the opportunity to participate in the optional B2B Partnering Program.

Don’t wait till its’ too late! Come and join us, register now!

Time: Nov 29 (Thur) – 30 (Fri)
Location: Grande Luxe Banquet (Flagship)
MEDTEX Info: https://bit.ly/2NUNbIg

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Pharmacogenomics (PGx): Tailoring Medicine to Your Genes
2024-04-01
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top